跳至主要内容
临床试验/ACTRN12605000040662
ACTRN12605000040662终止不适用

Management of CBD stones at laparoscopic cholecystectomy: A NSW collaborative prospective randomised trial to assess the value of transcystically inserted CBD stents to facilitate post-operative ERCP.

Sydney West Area Health Service0 个研究点目标入组 340 人开始时间: 2005年7月25日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
340

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
ot stated 至 -2147483648 No limit(—)
性别
All

入选标准

  • The patient must be able to give informed consent preoperatively (i.e. elective procedures only). Patients at higher than normal risk of having CBD stones identified at OC: a CBD stone identified at ultrasound; a wide CBD (>6mm) at ultrasound; previous, recent, current cholangitis, jaundice, or biliary pancreatitis; abnormal AST and ALT levels (>2 times normal).

排除标准

  • Pregnancy at time of surgery. Patients not fit for surgery. For example: those with acute cholecystitis or persistent obstructive jaundice; patients who have had a previous ERCP and sphincterotomy; those in whom intervention was not technically possible (eg. previous Billroth II gastrectomy).

研究者

发起方
Sydney West Area Health Service

相似试验

Management of CBD Stones At Laparoscopic... | 临床试验